RedHill Biopharma Ltd. RDHL
$ 7.95
-2.75%
Annual report 2023
added 10-19-2024
Country |
Israel |
IPO year |
- |
Industry |
Drug manufacturers |
Stock Exchange |
NASDAQ GLOBAL |
CEO |
Mr. Dror Ben-Asher |
Employees in the company |
155 |
Shares |
- |
Market Cap[1] |
$ 428 M |
EBITDA (LTM) |
$ -59.3 M |
P/E (LTM) |
1.11 |
P/S (LTM) |
0.4 |
EPS (LTM) |
0.19 |
Other stocks of industry "Drug manufacturers"
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.